{
  "docId": "019de075-0704-766b-8dc2-5164487e52e7",
  "docSlug": "289762853c89269e6344134613f84a84",
  "documentTitle": "OmniAb | Investor Presentation Deck | 39 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 39,
  "pageCount": 39,
  "prevPage": 38,
  "nextPage": null,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 27,
  "notes": "The slide uses a Gantt-style visualization to show the progression of drug candidates through clinical phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-0704-766b-8dc2-5164487e52e7/39",
  "deckHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7",
  "deckJsonHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7.json",
  "deckAnchorHref": "/decks/019de075-0704-766b-8dc2-5164487e52e7#slide-39",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.04,
        "y": 0.96
      },
      "kind": "legend",
      "text": "Indicates program with fully paid license from OMT, Inc. prior to acquisition. Programs discovered by Teneobio under a fully paid license. Future programs discovered under license agreement are subject to downstream economics.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "278838b2-1019-4f16-afd3-3d0b16b45171",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.04,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Animal launch year: OmniRat 2012; OmniMouse 2014; OmniFlic 2014; OmniChicken 2016; OmniClic 2019; OmniTaur 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69983f12-ff3e-4434-be10-5be555814579",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.04,
        "y": 0.93
      },
      "kind": "subtitle",
      "text": "Notes: Most advanced status for each program shown. Zimberelimab and Sugemalimab are approved and marketed in China. Teclistamab is approved and marketed in the US and EU with $35M launch milestones paid.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43df2dac-d3ae-4ad1-ab04-449823678633",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.73,
        "w": 0.92,
        "x": 0.04,
        "y": 0.17
      },
      "kind": "table",
      "text": "Partner, Program, Source Animal, Therapy Area, Target, Phase 1, Phase 2, Phase 3, Registration, Approved",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a088323-38f1-4668-9b88-b6b4d360411f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.75,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "title",
      "text": "THREE APPROVED PRODUCTS AND 24 ACTIVE CLINICAL-STAGE ANTIBODIES",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd52e798-b6cd-4d66-af30-d51cfeb0877f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.89,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Approved and Clinical-Stage Partner Pipeline as of 03/31/2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94e699a3-39c8-4f66-92cf-660bfe861cfa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "5639cd18-a806-4a83-96c6-1e8a96b83ce7",
      "evidence": "table/data: Partner, Program, Source Animal, Therapy Area, Target, Phase 1, Phase 2, Phase 3, Registration, Approved",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "33998210-a904-4b46-abfa-38b142a53ed4",
      "evidence": "The table uses horizontal bars to represent the clinical phase progression of each program.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 39,
      "from": 36,
      "beatId": "a12b5111-729d-4519-b37e-65b3de98a255",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "The deck concludes with a key takeaways and a timeline to prompt action.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}